casalonga logo

Case Law

Here you will find a selection of decisions from French and European courts, authorities, and offices. Various teams at CASALONGA were involved in some of the cases handled. Other cases are mentioned here due to their particular importance

2020-06-19

Paris Court of Appeal - BIOGARAN v/ GILEAD

BIOGARAN was represented by the CASALONGA team, composed of Marianne Gabriel and Arnaud Casalonga, attorneys-at-law at the Paris Bar.

This case involves "Truvada", a drug comprising tenofovir disoproxil combined with emtricitabine for the treatment of patients infected with the HIV virus causing acquired immunodeficiency syndrome or "AIDS".

Gilead is the owner of European Patent No. 0.915.894 (EP 894) entitled "nucleotide analogues" filed on July 25, 1997 under priority of US Patent 6868389 dated July 26, 1996, (...)